Articles

Subramanian A, Sulkowski M, Barin B, Stablein D, Curry M, Nissen N, Dove L, Roland M, Stock P, Ragni MV. MELD is an important predictor of pre-transplant mortality in HIV-infected liver transplant candidates. Gastroenterology 2010; 138: 159-164. PMID 19800334

Foley CM, Nichols LA, Jeoung K, Moore CG, Ragni MV. Atherosclerosis and cardiovascular mortality in hemophilia. J Thromb Haemost 2010; 8: 208-211. PMID 19874455

Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA, HTCN Study Investigators (Ragni MV). Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia 2009; 15:918-925. PMID 19473418

Ragni MV, Journeycake JM, Brambilla D. Tissue Plasminogen Activator to Prevent Central Venous Access Device Infection: A Systematic Review of CVAD Thrombosis, Infection, and Thromboprophylaxis. Haemophilia 14: 30-38; 2008.

Novelli E, Ragni MV. Genetics of Bleeding Disorders in Women. Sem Thromb Haemost 2008, 34:509-519.

Smith KJ, Monsef BS, Ragni MV. Should female relatives of factor V Leiden carriers be screened prior to oral contraceptives? A cost-effectiveness analysis. Thromb Haemost 2008; 100: 447-452.

Ragni MV, Jankowitz RC, Nichols TM. A phase II prospective open-label escalating dose trial of interleukin-11 (rhIl-11, Neumega®) in mild von Willebrand disease. Haemophilia 14:968-977,2008.

Ragni MV, Schillo R, Nalesnik MA, Dang Q. HAART improves ESLD-free survival in HIV-HCV co-infection. Haemophilia 2009; 15:552-558

Ragni MV, Wu W, Liang X, Cortese-Hassett A, Lu L. Factor VIII-pulsed tolerogenic dendritic cells reduce F.VIII inhibitor formation in the murine hemophilia A model. Exp Hematol 2009; 37:744-754.

Collins PW, Blanchette VS, Fischer K, Bjorkman S, Oh M, Fritsch S, Schroth P., Spotts G, Astermark J, Ewenstein B, RAHF-PFM Study Group (Ragni MV). Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylatic treatment for severe hemophilia A. J Thromb Haemost 2009; 7:413-420.

Culley CM, Guttendorf S, Coldren M, Skledar SJ, Gross PR, Spiro RM, Triulzi DJ, Ragni MV. Coagulation factor VIIa in non-hemophilic patients requiring neurosurgery. Am J Health-Syst Pharm 2009; 66: 1554-1559.

Madeira CL, Layman RE, DeVera ME, Fontes PA, Ragni MV. Extrahepatic factor VIII synthesis in transplant recipient of hemophilia donor liver. Blood 2009; 113: 5364-5365.

Ragni MV. Pulmonary embolism and CT scans. Curr Opin in Pulm Med 2009; 15:430-438.

Ragni MV, Ojeifo O, Hill K, Feng J, Yan J, Hill KA, Sommer SS, Trucco M, Brambilla DJ, and the Hemophilia Inhibitor Study Group Risk factors for inhibitor formation in hemophilia: A Prevalent Case-Control Study. Hemophilia 2009; 15: 1074-1082.

Konkle BA, Kessler C, Aledort L, Anderson J, Fogarty P, Kouides P, Quon D, Ragni M, Zakarija A, Ewenstein B. Emerging clinical concerns in the aging hemophilia patient. Haemophilia 2009, DOI: 10.1111/j.1365-2516.2009.x